Thomas Steyer’s Dynatrace DT Stock Holding History

Thomas Steyer’s Portfolio DT Stock Details DT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,788,269	Closed	-$329M	–	175
2023 Q1	$329M	Sell	7,788,269 -130,000	-2%	-$5.26M	1.8%	18
2022 Q4	$303M	Buy	7,918,269 +716,269	+10%	+$26M	1.79%	21
2022 Q3	$251M	Sell	7,202,000 -645,000	-8%	-$24.9M	1.38%	27
2022 Q2	$309M	Buy	+7,847,000	New	+$312M	1.68%	16

Other funds holding DT

Thoma Bravo Chicago, Illinois $7.28B AUM 35.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Thomas Steyer's DT Position: Q2 2023 in Review

Thomas Steyer sold out of Dynatrace (DT) in Q2 2023, closing a stake of 7,788,269 shares — an estimated $329M sold.

Thomas Steyer first reported a position in DT in Q2 2022 and held it in 4 quarters. The position peaked at $329M in Q1 2023. 472 funds tracked by Wall St. Rank hold DT as of Q2 2023.

Thomas Steyer reported no remaining Dynatrace position as of Q2 2023 after selling out during the quarter.
Thomas Steyer sold 7,788,269 Dynatrace shares in Q2 2023, an estimated $329M.
Thomas Steyer first reported a position in Dynatrace in Q2 2022 and held it in 4 quarters.
Thomas Steyer's Dynatrace position peaked at $329M in Q1 2023.
472 funds tracked by Wall St. Rank held Dynatrace as of Q2 2023.

Based on Farallon Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.